Novelix Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	6.79	1.18	2.75	28.9	20.8
Short-Term Investments	-	-	25	25	-	-
Trading Asset Securities	-	-	8.73	3.91	1.19	2.48
Cash & Short-Term Investments	14.5	6.79	34.91	31.66	30.09	23.28
Cash Growth	855.66%	-80.56%	10.26%	5.22%	29.25%	94.62%
Accounts Receivable	-	181.37	0.13	1.9	12.32	13.81
Other Receivables	-	1.58	2.83	3.66	3.89	4.76
Receivables	-	253.18	2.97	6.34	20.38	42.22
Inventory	-	8.43	3.21	4.29	8.77	6.78
Prepaid Expenses	-	0.18	0.01	0.13	0.08	0.02
Other Current Assets	-	0.75	0.2	-	-0	1
Total Current Assets	-	269.33	41.3	42.43	59.31	73.3
Property, Plant & Equipment	-	1.86	1.18	1.74	4.55	16.2
Long-Term Investments	-	0.43	30.64	27.75	4.22	3.9
Other Intangible Assets	-	0	0	0	0.11	0.32
Long-Term Deferred Tax Assets	-	0.45	0.54	0.65	0.66	-
Other Long-Term Assets	-	0	-	-	18.54	2
Total Assets	-	272.06	73.65	72.57	87.38	95.73
Accounts Payable	-	93.01	0.03	0.54	8.83	21.46
Accrued Expenses	-	3.36	0.07	0.07	0.09	0.13
Current Portion of Long-Term Debt	-	-	-	-	0.34	-
Current Income Taxes Payable	-	0.3	-	-	-	-
Other Current Liabilities	-	-	0	0.01	0.05	0.16
Total Current Liabilities	-	96.67	0.1	0.62	9.29	21.75
Long-Term Debt	-	-	-	-	1.31	-
Long-Term Deferred Tax Liabilities	-	-	-	-	-	0.33
Total Liabilities	-	96.67	0.1	0.62	10.6	22.08
Common Stock	-	99.5	81	81	81	81
Additional Paid-In Capital	-	94.65	12.15	12.15	12.15	12.15
Retained Earnings	-	-18.76	-19.6	-24.32	-22.74	-28.14
Comprehensive Income & Other	-	-	-	3.12	3.63	3.63
Total Common Equity	256.1	175.39	73.55	71.95	74.04	68.65
Minority Interest	-	-	-	-	2.74	5.01
Shareholders' Equity	256.1	175.39	73.55	71.95	76.78	73.65
Total Liabilities & Equity	-	272.06	73.65	72.57	87.38	95.73
Total Debt	-	-	-	-	1.65	-
Net Cash (Debt)	14.5	6.79	34.91	31.66	28.44	23.28
Net Cash Growth	855.66%	-80.56%	10.26%	11.31%	22.18%	442.70%
Net Cash Per Share	0.96	0.72	3.35	3.91	3.51	2.87
Filing Date Shares Outstanding	17.32	9.95	8.1	8.1	8.1	8.1
Total Common Shares Outstanding	17.32	9.95	8.1	8.1	8.1	8.1
Working Capital	-	172.66	41.2	41.81	50.02	51.55
Book Value Per Share	17.77	17.63	9.08	8.88	9.14	8.47
Tangible Book Value	249	175.39	73.55	71.95	73.93	68.32
Tangible Book Value Per Share	17.28	17.63	9.08	8.88	9.13	8.43
Buildings	-	-	1.43	1.43	1.43	-
Machinery	-	-	11.85	12.04	14.54	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.